{"entity":{"id":"nct06376136","kind":"trial","name":"A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors","aka":[],"tldr":"A phase 1/2 trial of BAT8010 for Injection in advanced solid tumours, run by Bio-Thera Solutions, active and no longer recruiting.","summary":"A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors is a phase 1/2 interventional study registered as NCT06376136 by Bio-Thera Solutions, with 216 participants planned, started 2024-05-08 and due to reach its primary completion in 2026-11-09. Interventions recorded: BAT8010 for Injection and BAT1006 for Injection.","status":"active","asOf":"2026-10-19","links":[{"label":"ClinicalTrials.gov NCT06376136","url":"https://clinicaltrials.gov/study/NCT06376136"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["bio-thera-solutions"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Registry status on 19 October 2026: Active, not recruiting (registry record last updated 30 September 2026; primary completion expected 29 February 2028)."],"nct":"NCT06376136","phase":"1/2","setting":"An Evaluation of BAT 8010 for Injection in Combination With BAT 1006 in Locally Advanced or Metastatic Entities Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of the Tumor in Patients Multicenter, Open Phase Ib/IIa Clinical Study","sponsor":"Bio-Thera Solutions","participation":[{"nct":"NCT06376136","source":"https://clinicaltrials.gov/study/NCT06376136","fetchedAt":"2026-10-07T16:54:36.402Z","studySha256":"22b0af4118758c09ac41e4142b7de3094467d4cf178bb36e24dc3d0120bb2faf","overallStatus":"ACTIVE_NOT_RECRUITING","lastUpdatePosted":"2026-09-30","leadSponsor":"Bio-Thera Solutions","collaboratorCount":0,"minimumAge":"18 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":218,"enrolmentType":"ESTIMATED","siteCount":1,"recruitingSiteCount":0,"countries":["China"]}],"started":"2024-05-08","startedType":"actual","enrolled":216,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06376136/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"company":[{"id":"bio-thera-solutions","kind":"company","name":"Bio-Thera Solutions","route":"/companies/bio-thera-solutions/"}]}}